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Abstract  
Background: The use of electrophysical agents has a historically important role in 
physiotherapy practice. There are anecdotal reports that the availability and usage of 
electrotherapy modalities is declining, which may have implications for physiotherapy 
practice. The aim of the literature review was to provide scientific evidence on 
electrotherapy usage in the last twenty years by identifying trends in availability, use and 
non-use of electrotherapeutic modalities in physiotherapy practice during 1990s and 
2000s.   
Methods: Review of empirical studies published in the English language from 1990 to 
2010 and identified through searching online bibliographic databases, which included 
Medline / OvidSP, PubMed Central, CINAHL/EBSCOhost, ScienceDirect, Scopus, ISI Web of 
Science and Google Scholar. 
Findings: In the last twenty years, ultrasound availability and usage show increasing 
trends in several countries. The availability and use of pulsed shortwave diathermy 
 2 
(PSWD) and laser have shown steady trends. Transcutaneous electrical nerve stimulation 
(TENS), interferential and biofeedback availability and usage have shown increasing 
trends in the UK and decreasing trends in Australia and the Republic of Ireland. Trends of 
continuous shortwave diathermy (CSWD) availability and use are declining irrespective of 
the country of the study. The availability and usage of microwave diathermy (MWD) and 
H-wave show steeply declining trends while there is a sharp rise in their non-availability 
over the last several years.   
Conclusions: The availability and use of electrophysical agents have greatly changed in 
the last twenty years.  Declining trends in the availability and usage along with rising 
trend of non-availability of electrotherapy modalities may have implications for 
electrotherapy education, training and the practice in the coming years.  
 
Keywords: electrotherapy, physical therapy, physiotherapy, survey, therapeutic 
diathermy, therapeutic ultrasound, thermal modality. 
 
INTRODUCTION 
Electrotherapy is the main module of physiotherapy practice.1, 2 It is provided using 
different electrophysical agents (EPAs) such as therapeutic ultrasound, shortwave 
diathermy (used in pulsed (PSWD) and continuous (CSWD) modes), microwave 
diathermy (MWD), interferential, transcutaneous electrical nerve stimulation (TENS), 
biofeedback, laser, and H-wave.2-4  
The use of electrical energy for therapeutic purpose goes back as far as the 18th 
century.5 Electrotherapy has been used for treating different medical conditions6. For 
example, use of diathermy for treating various gynaecological conditions7 such as the use 
of microwave diathermy before conception and during early pregnancy.8 In addition, 
shortwave diathermy has been used as early as in 1940 for treating nasal sinus 
infections.9 In addition, a number of other electrotherapy modalities have been 
introduced and used since late 1980s and early 1990.10 However, some of electrotherapy 
modalities most commonly used in the past are becoming less popular2 while other 
electrotherapy modalities have become popular. For example, PSWD, used since its’ 
development in the 1940s11 became popular,12 but more recently has started declining.13 
In addition, interferential, despite not being very new, also became popular among 
physiotherapists in the 1980s and thereafter.14, 15 Moreover, some electrotherapy 
modalities most commonly used in the past have become less popular.2 For example, 
CSWD used widely since the 1930s started declining in the 1950s 13 and by 2007 is rarely 
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used.11, 13, 16 MWD used frequently before the 1970s17 became rarely used in recent years 
in Australia16, 18 while since 2007 it is not available and therefore not used in the UK.16 
Conversely, very recently ultrasound, TENS, and  interferential enjoyed the status of the 
most commonly available and used electrotherapy modalities.1, 16, 18 In addition, either 
using or not using a particular EPA has become a challenge in physiotherapy practice for a 
number of reasons, such as physiotherapists’ use of evidence based practice, emphasis on 
physical exercise and manual therapies as well as a lack of evidence in clinical 
effectiveness of electrotherapy modalities.2, 19, 20  Hence, there may be implications for 
teaching and training of electrotherapy in the physiotherapy discipline.19, 21, 22 For 
example, there has been exclusion of MWD from a very recent text book on 
electrotherapy.20 It is therefore important to assess scientific evidence as to the degree to 
which electrotherapy modalities are available and used, available but not-used and not-
available in physiotherapy practices. There is however no systematic study to inform the 
trends in the usage of electrotherapeutic modalities. Therefore, there is a need to fill this 
gap in the literature and update the body of knowledge on the usage of electrotherapy 
modalities. 
Aims and objectives 
The aim of this systematic literature review is to provide a scientific evidence on trends in 
the availability and usage of nine different types of electrotherapeutic modalities i.e. 
ultrasound, PSWD, CSWD, MWD, interferential, TENS, biofeedback, laser and H-wave in 
physiotherapy practices in the last twenty years from 1990 to 2010.  
METHODS 
Definition of Physiotherapy practice 
In this review, the term physiotherapy practice was defined as ‘any physiotherapy 
department or clinic in the public or private healthcare sector’. 
Electrophysical agents studied 
Electrophysical agents included in this review were therapeutic ultrasound, 
radiofrequency electromagnetic radiation (pulsed shortwave diathermy (PSWD), 
continuous shortwave diathermy (CSWD), microwave diathermy (MWD), interferential, 
transcutaneous electrical nerve stimulation (TENS), biofeedback, laser and H-wave.  
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Inclusion criteria 
Inclusion criteria were empirical primary research studies in the English language 
published between January 1990 and June 2010.  Study designs included were cross 
sectional surveys and audits of electrotherapy equipment, availability, use and non-use in 
physiotherapy departments and clinics. The outcomes investigated included the 
availability and usage of any or all of the nine electrotherapy modalities mentioned above.  
Exclusion criteria 
Discursive, hypothetical and review articles and studies in languages other than English. 
Databases searched 
Literature searches were conducted through several online bibliographic databases i.e. 
Medline / OvidSP, PubMed Central, CINAHL/EBSCOhost, ScienceDirect, Scopus, ISI Web of 
Science and Google Scholar.  
Keywords used  
The keywords used for literature searches were: electrotherapy, equipment, survey, 
electrophysical agents, physiotherapy, electrotherapeutic, devices, use, usage, availability, 
therapeutic, diathermy, microwave and shortwave. These keywords were searched using 
two Boolean search operators i.e. ‘AND’ and ‘OR’ through the above mentioned 
bibliographic databases. The process of the literature search is explained below.  
Search strategy, article shortlisting and data abstraction 
A team of two researchers (the authors) were involved in the literature review process. 
Using the above mentioned keywords and databases, SGSS conducted literature searches, 
shortlisted and reviewed the relevant articles and abstracted the data. AF supervised the 
process of the literature review and checked the abstracted data, which involved referring 
back to the original article(s) if required. Abstracted data was accepted with the 
consensus of both researchers (the authors).  
The process of identification of relevant articles included reading the title, 
followed by review of the abstract and creation of a shortlist of relevant articles for full 
review. The process of selecting the research, shown in Figure 1 led to identification of 23 
studies.  Full text was obtained for these studies (n=23), which were reviewed and the 
data was abstracted for the publication year, location of the study, aims and objectives, 
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study design, data collection tool, sample size, response rate and the key findings with 
respect to the availability, use, non-use and non-availability of the nine electrotherapy 
modalities as shown in Table 1. This table also provides the reviewers’/ authors’ (our) 
comments / remarks on the studies included in this review. In a study by Pope et al.,23 the 
authors only reported the total number of physiotherapists who had access to different 
electrotherapy modalities but they did not report the absolute number revealing the 
overall availability of devices for each modality surveyed in their study.  
The present authors (reviewers) therefore determined the availability of 
electrotherapy modalities by the number of physiotherapists who had access to 
equipment of each modality divided with the total respondents in the study by Pope et 
al.23 In addition, for studies that only reported equipment availability, we determined 
non-availability of equipment using the following formula.   
 
Non-availability of equipment (%) = (total respondents who reported equipment 
availability ∕ total respondents in the study) × 100.   
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66 articles identified through title 
review of search results 
43 articles shortlisted for abstract 
reviewing 
25 articles identified for full 
article review 
23 studies included in this 
literature review and used for 
data abstraction 
23 duplicates removed
18 articles excluded at 
abstract review
2 articles excluded at full 
article review
 
 
Figure 1 Flow chart of studies included and excluded in this literature review 
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Table 1 Data extracted from reviewed studies on the availability and usage of electrophysical agents in physiotherapy practices  
Authors (year) Location Aims/objectives Participants;  
Sample size= N 
Design; 
(Response 
rate) 
Findings Reviewers' comments 
Lindsay et al. 
199024 
Brisbane, 
Australia 
Survey of 
ownership, 
frequency of use 
and factors 
affecting the 
pattern of use of 
electrotherapeutic 
modalities 
Private 
physiotherapy 
practices;  
N =105   
Questionnaire 
survey;  
(70%) 
Physiotherapists aged <31 years 
more likely to use TENS than those 
≥31 years (p <0.05).  US owned by 
100%; PSWD 20%, CSWD 66%; laser 
17%, interferential 85%; TENS 92%; 
biofeedback 24% and MWD 33% of 
clinics. Frequency of use for those 
owning equipment: US 93%, PSWD 
68%, CSWD 68%, laser 58%, 
interferential 90%, TENS 21%, 
biofeedback 18% and MWD 79%. 
Main reasons for use were 
‘effectiveness and portability’ for 
TENS and  ‘effectiveness’ for  CSWD. 
Major reasons for non-use were cost 
and safety for CSWD and cost for 
PSWD. For MWD, the main reasons 
for frequent use were ‘effectiveness’ 
Issues of safety, whether for the 
physiotherapist, the patient or 
both were not clear.  No report on 
the number of devices available 
in each practice. This small study 
included only private clinics in 
Brisbane and findings cannot 
therefore be generalized, but 
suggested a regional trend of 
electrotherapy. 
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and ‘ease of application’ and safety 
was the main concern for non-use. 
The reasons for non-ownership were 
cost, unfamiliarity and questionable 
effects for laser and a lack of need for 
biofeedback.   
Baxter et al. 
199925 
Northern 
Ireland 
(UK) 
To evaluate use of 
therapeutic laser 
Physiotherapists; 
N =148 
Postal 
Questionnaire 
Survey in 2 
stages; (63%, 
n=116) 
Therapeutic laser was used mainly 
for burns but also for rheumatoid 
arthritis, various types of ulcer and 
shingles. A lack of information 
especially about the parameters of 
optimal treatment with laser was 
reported. 
No information presented on the 
number of devices per 
department. Research design and 
selection of the sample was not 
clear. This was a regional study 
and therefore not generalizable 
but suggested a regional trend of 
laser usage in clinical practice. 
Taylor and 
Humphry 
199126 
USA Use of 
electrophysical 
agent modalities 
Physiotherapists 
(specialist in 
physical 
disabilities);  
N=997 (randomly 
selected) 
Postal 
Questionnaire 
Survey; (63%, 
n=629) 
Figures on availability of devices not 
reported. Hot and cold packs were 
most commonly used.  Use of US was 
86%, TENS 88% and neuromuscular 
electrical stimulation (NMES) 89%. 
Use of several times / week equal for 
NMES and US but lower for TENS. 
Non-use was highest for US (14%) 
Limited scope of the study on use 
of EPAs because participants 
were from one specialist group of 
physiotherapists in physical 
disabilities practice. Not known 
whether this survey covered both 
public and private practices. No 
precise data given on overall 
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followed by TENS (13%) and NMES 
(11%). Non-use of any 
electrotherapy modality was 
reported by 23% of physiotherapists. 
Most common mode of receiving 
training for US, TENS and NMES was 
‘on job training’. No training was 
received by 11% for US, 9% for TENS 
and 7% for NMES. 
availability of PSWD, CSWD, 
MWD, biofeedback, laser, or H-
wave; thus, providing limited 
knowledge on EPAs as a whole. 
McMeeken and 
Stillman 
199327 
Victoria, 
Australia 
Use of therapeutic 
laser 
Physiotherapists; 
N = 122 
Questionnaire 
Survey;  (31%, 
n=38 ) 
The maximum number of laser 
equipment was 3 devices per 
practice. The value of using laser was 
questioned and a lack of information 
about laser use and effectiveness 
was reported. 
Mainly addressed clinical efficacy 
of therapeutic laser; hence less 
relevant but did not inform on 
frequency of use. As a regional 
Australian study, it cannot be 
representative of Australia as a 
whole. Moreover, sampling 
strategy was not random as 
compiled with information from 
laser manufacturers / suppliers 
and other sources such as 
healthcare professionals. 
Kitchen 199528 England (6 Use of PSWD, Physiotherapists Face to face US, PSWD and CSWD devices were Exploratory study with a small 
 10 
health 
regions) 
CSWD, ultrasound 
and laser in clinical 
practice 
(NHS and 
private); N = 10 
interviews; 
(100%, n=10) 
available to all participants (n=10) 
while laser equipment was available 
to 40% (n=4) of participants. 
Personal experience and availability 
were the two main reasons for 
selection of the modalities. Doubts 
about the efficacy of electrotherapy 
agents were also reported.  The 
occurrence of a number of adverse 
reactions due to these modalities 
was reported. 
sample (n=10) over six health 
regions; location of the health 
regions was not described. Mainly 
referred to use of CSWD, PSWD, 
US and laser for management of 
soft-tissue problems and the 
factors affecting the selection of 
the modality. Hence, this study 
has less value for assessing the 
availability and use / non-use of 
EPAs. The occurrence of adverse 
reactions was not clear whether 
patients or physiotherapists 
experienced them. 
Lindsay et al. 
199529 
Alberta, 
Canada 
To survey all 
private 
practitioners 
registered within 
the Province of 
Alberta regarding 
modality usage 
Physiotherapists, 
N = all private 
practitioners 
registered within 
the Province of 
Alberta 
Questionnaire 
Survey; (41%, 
n=208) 
Electrotherapy was a common 
treatment mode. US, interferential 
and TENS were most frequently 
used. Frequent use of TENS was 
greater amongst older 
physiotherapists and clinic owners 
(p < 0.05). [Similar to 1990 results 
by same researchers carried out in 
Reported availability of PSWD 
and CSWD equipment as ‘high’ 
but did not report exact number 
of devices per department. There 
was no report on the non-use of 
modalities. Moreover, this study 
covered only private 
physiotherapists in the region of 
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Australia24] Male physiotherapists’ 
use of biofeedback was greater than 
female physiotherapists’ use of this 
modality (p < 0.05). 
Alberta; hence, the findings could  
not be representative of 
physiotherapists in both public 
and private sectors across 
Canada. 
Pope et al. 
199523 
England To study 
ownership and use 
of electrotherapy 
equipment   
Senior 
physiotherapists 
in 139 hospitals 
in 14 regional 
health Authorities 
(RHAs), random 
sampling 
Questionnaire 
Survey; (84%, 
n=116 
hospitals) 
More than one reply from each 
hospital: total replies = 213. The 
reported ownership was US by 212 
respondents, PSWD 209, CSWD 196, 
laser 196, interferential 207, TENS 
209, biofeedback 176, MWD 178 and 
H-wave 173 respondents. Use with 
ownership was US 100%, PSWD 
97%, CSWD  65%, laser 93%, 
interferential 99%, TENS 99%, 
biofeedback 94% and MWD 64% and 
H-wave 97%.  Non-use despite 
ownership was PSWD by 3%, CSWD 
35%, laser 7%, interferential 0.5%, 
TENS 1%, biofeedback 6%, MWD 
36% and H-wave 3%. Reasons for 
non-use despite ownership for US 
No exact sample size of 
physiotherapists reported. 
Report of final response rate was 
not clear as to whether response 
was a hospital or a 
physiotherapist. Figures on 
ownership and use / non-use 
were not clearly reported.  No 
explanation of unfamiliarity with 
some modalities given. Some of 
the hospitals provided more than 
one response. 
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were not reported. Most common 
reasons for not purchasing CSWD, 
laser, biofeedback, MWD and H-wave 
equipment were unfamiliarity with 
the modalities, lack of clinical 
evidence and high cost. 
Kitchen and 
Partridge 
199630 
England Survey of 
availability and 
frequency of use 
US, SWD and laser 
for treating of soft 
tissue lesions 
(Part-1) 
Physiotherapists, 
N = 111 (in 14 
NHS outpatient 
departments, one 
each in 14 health 
services regions), 
stratified random 
sampling 
Postal 
Questionnaire 
Survey; (89%, 
n=99). 
Responses 
analyzed = 98 
Availability of equipment of US 
(pulsed and continuous) was 100%, 
PSWD 98%, CSWD 85% and laser 
33%. Frequency of use more than 
once per week: pulsed US 76%, 
continuous US 56%, PSWD 76%, 
CSWD 16% and laser 32%. Overall, 
laser was used by 97% of (i.e. 32 out 
of 33) physiotherapists with access 
to it. Physiotherapists preferred the 
use of non-thermal modalities 
(PSWD) to thermal modalities 
(CSWD) in treating a variety of soft 
tissue lesions at the NHS outpatients 
departments. 
A very high response rate was 
achieved but the participants 
were only those physiotherapists 
who used electrotherapy and not 
every physiotherapist working in 
a participating department; 
hence, the findings might be less 
representative. Moreover, the 
focus of this study was on the 
types of soft tissue lesions and 
not on the types of electrotherapy 
modalities. 
Seymour and Trent Survey of Physiotherapists Postal Of respondents, 92% were female, No report on how many 
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Kerr 199631 region, 
England 
community based 
physiotherapists 
(community 
based in Trent 
RHA); N = 150 
Questionnaire 
Survey; (65%, 
n=97) 
54% were aged 31-40. The workload 
for 57% physiotherapists was 6-10 
patients/day. Use of electrotherapy 
modalities by physiotherapists was 
73% for US, 3% for PSWD, 30% for 
interferential and 44% for TENS. 
97% of physiotherapists received in-
service training, usually once each 
month. 
participants had access to 
electrotherapy equipment and 
how many did not use the 
equipment despite availability. 
This was another example of a 
local study representing the area 
covered by a health authority in 
the north of England. Only public 
sector community 
physiotherapists were involved 
providing limited information of 
physiotherapists’ practices within 
the wider geographical 
boundaries of the Trent RHA. 
Kitchen and 
Partridge 
199732 
England Study of use of US, 
SWD and laser for 
management of 
soft tissue lesions 
(Part-2) 
Physiotherapists; 
N = 111 (in 14 
NHS outpatient 
departments, one 
each in 14 health 
services regions) 
stratified random 
sampling 
Postal 
Questionnaire 
Survey; (89%, 
n=99). 
Responses 
analyzed= 98 
The pattern of availability and use of 
US, PSWD, CSWD and laser was the 
same as reported in the above 
mentioned study by Kitchen and 
Partridge (1996)31, which was part-1 
of this study. In addition, this article 
reported a number of factors 
affecting selection of electrotherapy 
This was Part II of Kitchen and 
Partridge (1996) study; hence, 
our comments are the same as 
those reported above for the said 
study. 
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modalities for treating different 
types of soft tissue lesions. 
Description of these lesions and 
factors is out of the scope of this 
review; hence not reported here. 
Robertson and 
Spurritt 
199833 
Tasmania 
and 
Victoria, 
Australia  
Study of the 
availability and use 
of electrophysical 
modalities 
Physiotherapy 
facilities (general 
hospitals, private 
practices, 
community clinics 
and rehabilitation 
centres); N =206 
Postal 
Questionnaire 
Survey; (78%, 
n = 160) 
Availability of EPA: US 96%, SWD 
52% (which included 36% for CSWD 
and 30% for combined PSWD and 
CSWD), laser 12%, interferential 
77%, TENS 86%, biofeedback 32%, 
and MWD 7% of facilities. Use of 
modalities was US 100%,  combined 
PSWD and CSWD 70%, only CSWD 
86%, laser 100%, interferential 66%, 
TENS 96% and MWD 75%. 
Frequency of use of ‘at least daily’ 
was 81% for US, 51% for combined 
PSWD and CSWD, 43% for CSWD, 
70% for laser, 53% for interferential 
and 83% for MWD.  Most common 
frequency of use of ‘at least monthly’ 
was for TENS in 50% of facilities. 
Study targeted facilities with 
placements for physiotherapy 
students but no clear sampling 
method was reported. This 
sampling strategy may bias 
reporting the availability / use of 
electrotherapy modalities 
compared to other facilities 
without placements. There was 
no report of the number of 
devices for each modality at each 
facility. Nevertheless, this study 
had a high response rate and 
most of the electrotherapy 
modalities were covered. 
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Three most common reasons for 
using US, interferential and TENS 
were: known effects, ease of 
application and availability. 
Availability of alternative method 
and safety were two of the most 
common reasons for non-use. 
Partridge and 
Kitchen 199934 
England 
and Wales 
(UK) 
Phase-I: Adverse 
health of 
electrotherapy in 
patients)  
Phase-II: Adverse 
health in patients 
with neurological 
conditions  
Physiotherapy 
departments in 
NHS hospitals; N 
= Phase-I = 200; 
Phase-II= 145 
Postal 
Questionnaire 
Survey: (Phase 
I: 74%, n=148); 
Phase II: 80%, 
n =116) 
Phase-I did not report availability or 
use of EPAs. Adverse health due to 
use of modalities reported for 
patients and not relevant here.  
Phase-II found 52% of 
physiotherapists working in 
neurology were in senior 1 grade. 
70% did not use electrotherapy in 
neurological conditions. Use of 
electrotherapy during previous year 
was reported by 55% for US, 8% for 
SWD, 7% for laser. 14% for 
interferential and 58% for TENS. 
Remaining participants did not use 
these modalities. 
Focus on health effects in 
patients; therefore, less relevant 
to this review. However, it 
provided some data on the use of 
EPAs. Use of SWD was reported 
but no details of PSWD and CSWD 
given. Study provided little 
information on electrotherapy 
modalities overall. 
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Cooney et al. 
200035 
Republic of 
Ireland 
Study of 
availability and use 
of electrotherapy 
modalities in 
public and private 
physiotherapy 
practices 
Physiotherapists; 
N = 120 (public = 
40 and private 
=80) 
Postal 
Questionnaire 
Survey; (Total 
=72%, n=86; 
public sector = 
88%,  n=35; 
private 
practitioners = 
64%, n=51) 
Availability of equipment was US 
95%, PSWD 39%, CSWD 37%, laser 
38%, interferential 98%, TENS 97%, 
biofeedback 3%, MWD 6% and H-
wave 2%. Availability of PSWD, 
CSWD, laser, TENS, biofeedback and 
MWD equipment was higher in 
public sector practices while US, 
interferential and H-wave equipment 
was higher in private practices. US, 
Interferential and TENS were used 
by 100% of facilities. Frequency of 
use of ‘2-3 days/ week’ was 90% for 
US, 53% for PSWD, 10% for CSWD, 
59% for laser, 95% for interferential, 
15% for TENS while MWD was used 
least. Non-use was higher in the 
public sector. Wishing to purchase 
equipment was reported by 8% for 
US, 18% for PSWD, 41% for laser and 
11% for TENS. There was no desire 
to purchase MWD or H-wave due to 
The sample size was small, 
particularly for public sector 
physiotherapists; thus, limiting 
the generalizability of findings. 
The reasons for selection or non-
use of the surveyed modalities 
were not reported. None of the 
modalities was reported to has 
ceased to be used.   However, the 
study provided better 
information on purchase of 
equipment although it was 
difficult to know the exact status 
of device ownership. 
 17 
these being superseded by other 
modalities. Cost was the main 
consideration for not buying PSWD, 
CSWD and laser in private practices. 
Shields et al. 
200136 
Republic of 
Ireland 
Survey of the 
availability, use, 
age, non-use and 
intention to 
purchase PSWD 
and CSWD 
Physiotherapy 
facilities; N =240 
(82 hospital 
departments and 
158 private 
practices) 
Postal 
Questionnaire 
Survey; (Total 
= 96%, n=231; 
hospital 
departments = 
95%, n=78; 
private 
practices = 
97%,  n=153) 
Availability of SWD: 65% in hospital 
departments (CSWD and PSWD in 
54%) and 12% in private practices 
(CSWD in 5%, PSWD in 4%). Non-use 
despite availability was 12% of 
hospital departments and 33% of 
private clinics. The number of 
available devices was 1-3 
devices/department; one 
device/department in 51% of 
hospital departments and 92% of 
private practices.  SWD devices were 
<10 years old in 43% of hospital 
departments and 46% of private 
practices. Among 35% of hospital 
departments and 89% of private 
practices with no SWD devices, 
reasons for non-purchase included 
A high response rate, which 
provides results that are the most 
representative and more 
generalizable. However, only 
SWD was covered. No details on 
safety issues (neither for patients 
nor for physiotherapists) were 
reported; however, the issue of 
evidence on clinical effectiveness 
of SWD (both PSWD and CSWD) 
was raised. 
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nature of the patients, lack of space, 
cost, lack of evidence for clinical 
efficacy and safety concerns. In 
hospitals, SWD servicing and quality 
control testing were carried out in 
53% and 49% respectively, most 
commonly every six months by 
external contractors. In private 
clinics, servicing (58%) and quality 
control testing (50%) were carried 
out generally less than once a year 
by an external contractor. 
Shields et al. 
200237 
Republic of 
Ireland 
Study of safety 
issues and clinical 
effectiveness of 
PSWD and CSWSD 
Senior 
physiotherapists; 
N= 116 (in 41 
hospital 
departments)  
Postal 
Questionnaire 
Survey; (75%, 
n =87), 
Responses 
analyzed = 83 
Approximately 65% of participants 
were senior physiotherapists, with 
mean time since qualification of 12 
years. Equipment availability was US 
99%, PSWD 94%, CSWD 93%, laser 
63%, interferential 100% and TENS 
99%. ‘Frequent or often’ use was 
reported by 91% for US, 45% for 
PSWD, 21% for CSWD, 76% for laser, 
73% for interferential and 58% for 
Reported total response rate was 
75% (n=87); however, only 83 
responses were analyzed; hence, 
the effective response rate of this 
study was 72%. This reduced 
response rate was not reported. 
Reporting of electrotherapy 
equipment availability was given 
in percentages with no actual 
number of departments. It was 
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TENS. Non-use despite availability 
was 12% for PSWD, 44% for CSWD, 
12 % for laser and 1% for 
interferential. No respondent 
reported non-use for US and TENS. 
The mean period for using PSWD 
and CSWD was 10 (±6) and 14 (±9) 
years respectively. PSWD and CSWD 
were not used in 10% (n=9) of 
departments. The majority used 
capacitive method and air space 
drums during SWD. Measures for 
physiotherapists’ safety included 
keeping a distance of 3m between 
SWD equipment and metallic objects, 
no use of other modalities within the 
same vicinity, a separate room for 
SWD treatment, notification of SWD 
use to other physiotherapists 
particularly pregnant colleagues and 
advice to therapists to leave the 
room during the treatment. 
therefore difficult for reviewers 
to ascertain whether the total 
completed / returned surveys or 
the total analyzed surveys were 
included. No information on the 
frequency of use of 
electrotherapy by a 
physiotherapist per day or per 
week. The study largely 
addressed operator safety issues, 
and provided valuable discussion 
on safety issues and raised 
concerns regarding a lack of 
adherence to physiotherapists’ 
safety guidelines. 
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However, taking no measures for 
physiotherapists’ safety was 
reported by 30% of respondents.   
Warden and 
McMeeken 
200238 
Victoria, 
Australia 
To assess the 
availability, 
frequency of use 
and dose of 
ultrasound in 
treating sports 
injuries 
Physiotherapists 
(in sports 
injuries); N = 355 
Postal 
Questionnaire 
Survey; (48%, 
n=171) 
There were 60% male respondents 
(n=102). Median experience (10 
years) and workload of 15 patients / 
day. US devices were available to all 
respondents. The most common 
pattern of use was ‘at least daily’ 
(84%, n=143). Treatment with US = 
25% of total patients; 4 patients / 
day (median figures). The main 
factors in deciding dose of US were 
training during graduate degree 
(83%) and experience (76%). Of 
respondents, 72% reported a lack of 
research evidence for US therapy.   
The response rate was 
comparatively low and only 
sports physiotherapists were 
selected suggested a source of 
bias in favour of champions for 
providing US therapy for sports 
injury. Therefore, the findings 
cannot be representative of US 
usage in physiotherapy practice 
in Australia as a whole. 
Chipchase and 
Trinkle 200339 
Southern 
Australia 
To determine the 
frequency and 
trends of use and 
effectiveness of US   
Physiotherapists 
(special interest 
in 
musculoskeletal); 
N = 380 (public 
Postal 
Questionnaire 
Survey; (55%, 
n=210) 
Once/day and an average of 33% 
(±2) of treatments involved US 
therapy. The four most frequently 
used EPAs were US, interferential, 
CSWD and TENS. Healing of tissues 
The response rate was moderate. 
The study involved both private 
and public sector 
physiotherapists but the 
breakdown was not reported.  
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and private) and thermal effects were two main 
reasons for using US. 
The frequency of use was 
calculated by the number of 
patients / week treated with US, 
not by the actual number of 
sessions of US therapy. This study 
involved only physiotherapists 
interested in musculoskeletal 
injuries. No details given about 
the number of respondents who 
were actually working in 
musculoskeletal physiotherapy. 
The findings may not be 
representative of all 
physiotherapists working in 
(Southern) Australia. 
Al-Mandeel 
and Watson 
200640 
England 
(North) 
Use of PSWD Patient records; N 
= 1750 patient 
files in 8 hospitals 
Audit; 
(response rate 
= Not 
applicable) 
Total number of patients treated 
with PSWD = 192. Treatments with 
PSWD = mean 11% (range 8%-13%). 
Treatment time = mean 12 (range 5-
20) minutes/session. Frequency of 
PSWD use: 1/week = 76%, 2x/week 
= 20%, 3x/week = 5%. 
This clinical audit determined 
PSWD use through patients’ case 
notes, finding only a small per 
cent of patients treated with 
PSWD; no information as to 
whether PSWD equipment was 
available but not used or not 
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available. This audit provided 
valuable information on duration 
of PSWD treatment although 
information was incomplete in 
the majority of patient files. 
Tabasam and 
Johnson 
200641 
England 
(North) 
Use of 
interferential for 
pain management 
Physiotherapists; 
N = all 
physiotherapists 
in 4 hospitals 
Postal 
Questionnaire 
Survey, (Not 
stated) 
Interferential use by 91% (n=57). 
Frequency of use: 63% (n=36), used 
for pain relief: 61% (n=35) of which 
71% treated less than 25% of total 
clinic patients. Average treatment 
time with interferential was between 
11 and 20 minutes.   
This small regional study, 
involved physiotherapists from 
only 4 hospitals. Neither the 
actual sample size nor the 
response rate reported. It was the 
only study that focused on 
interferential use but only in pain 
management. The findings on 
interferential use very specific 
but did not represent overall 
pattern of use of this modality. No 
details about non-availability and 
non-use reported. 
Shah et al. 
200716 
England 
(Southeast 
and 
Southwest 
The availability 
and use of 
electrotherapy 
equipment 
NHS 
Physiotherapy 
departments 
(N=46), random 
Postal 
Questionnaire 
Survey (100%) 
Availability of equipment: US 100%, 
PSWD 93.5%, CSWD 30.4%, laser 
50%, interferential 95.7%, TENS 
82.6%, biofeedback 84.8%, MWD 0% 
Response rate excellent but 
sample size moderate. Involved 
only NHS physiotherapy 
departments and clinics located 
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including 
London) 
and H-wave 6.5%. 
Use: US 80.4%, PSWD 69.6%, CSWD 
8.7%, laser 37%, interferential 
76.1%, TENS 60.9%, biofeedback 
65.2%, MWD 0% and H-wave 2.2%. 
Non-use despite availability: US 0%, 
PSWD 15.2%, CSWD 89.1%, laser 
52.2%, interferential 4.3%, TENS 
17.4%, biofeedback 17.4%, MWD 0% 
and H-wave 93.5%. 
Available but no information about 
use: US 19.6%, PSWD 15.2%, CSWD 
2.2%, laser 10.9%, interferential 
19.6%, TENS 21.7%, biofeedback 
17.4%, MWD 0% and H-wave 4.3%. 
None availability was US 0%, PSWD 
6.5%, CSWD 69.6%, laser 50%, 
interferential 4.3%, TENS 17.4%, 
biofeedback 15.2%, MWD 100% and 
H-wave 93.5%. 
in Southeast and Southwest 
England including London. 
Showed a regional trend. 
Findings might not be 
representative of the whole NHS. 
Wong et al. 
200742 
USA 
(Northeast 
Use of therapeutic 
ultrasound 
Physiotherapists 
(orthopaedic 
Postal 
Questionnaire 
60% of physiotherapists reported 
likely to use US for ≥25% of patients 
Response rate was moderate and 
this study involved 
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and Mid-
Atlantic 
regions) 
specialists); N = 
457 
Survey,; 
(45.3%, n=207) 
and 40% reported unlikely to use US 
for ≤10% of patients.  50% reported 
US as clinically important, 35% 
reported as not important and 15% 
would not use US. 
physiotherapists from only one 
specialist group (i.e. orthopaedic 
specialists). Therefore, the 
findings cannot represent US 
usage by all physiotherapists in 
the survey regions in the USA. 
Moreover, the usage was 
reported only for pain, (soft) 
tissue inflammation, healing, 
swelling and scar remodelling. 
The clinical importance was also 
studied with respect to the 
conditions above, but there was 
no information about the overall 
effectiveness of US in 
physiotherapy practice. 
Therefore, findings cannot be 
generalized to overall 
physiotherapy practice. 
Chipchase et 
al. 200918 
Australia Availability and 
usage of EPAs 
Physiotherapists; 
N = 12893 
Postal 
Questionnaire 
Survey; (27%, 
Availability of equipment:  US 90%, 
PSWD 11%, CSWD 12%, laser 32%, 
interferential 72%, TENS 82%, 
Sampling of participants was 
limited to those physiotherapists 
who had consented to release of 
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n = 3538) biofeedback 52% and MWD 2%. 
Daily use: US 37%, PSWD 1%, CSWD 
2%, laser 5%, interferential 24%, 
biofeedback 8%, and MWD 0.2%. 
Non-use despite equipment 
availability: US 22%, PSWD 96%, 
CSWD 95%, laser 81%, interferential 
24%,  TENS 30%, biofeedback 58% 
and MWD 99%. 
their contact details; the response 
rate was therefore very low. 
Thus, major limitations to the 
generalizability of findings 
applicable to Australia as a whole. 
The study did not cover all 
modalities, e.g. H-wave was not 
surveyed. No reasons were stated 
for non-use despite availability of 
equipment and no implications 
were discussed for widespread 
non-use of available equipment. 
Scudds et al. 
200943 
UK and 
Hong Kong 
(HK) 
Use and 
effectiveness of 
TENS compared to 
other EPAs in pain 
treatment 
Physiotherapists; 
N =1200 (600 
each from the UK 
and HK),  random 
sampling 
Postal 
Questionnaire 
Survey; 
(Overall 34.7%, 
n=416;  UK 
=35%, n=211;  
HK =34%, 
n=205) 
Usage of electrotherapy modalities 
for pain management was US 86%, 
SWD 50%, laser 48%, interferential 
78% and TENS 98% in HK and US 
72%, SWD 24%, laser 22%, 
interferential 64% and TENS 79% in 
the UK. 
Sample was randomly selected 
but response rate was low. The 
generalizability of findings 
limited due to participants 
comprising <1% of the total 
registered physiotherapists in the 
UK and only 9% of those in Hong 
Kong. The data on the use of EPAs 
was presented only in graphical 
format: the reviewers’ 
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determining the % of use by 
viewing the graph. No breakdown 
of SWD into separate use of 
PSWD and CSWD. Authors’ 
emphasis was on differences 
rather than similarities between 
practices in the two countries. 
The study determined use of 
selected EPAs for only one 
medical issue i.e. pain. 
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FINDINGS 
The types of electrotherapy modalities that were investigated in 23 studies included 
in this literature review are shown in Table 2.  
The extracted data revealed that 12 (52.2%) studies were published during 
the 1990s and 11 (47.8%) studies were published in the 2000s. All of these studies 
were conducted in English speaking countries: Australia (n=6), Canada (n=1), 
England (n=8), England and Wales (UK) (n=1), Hong-Kong and UK (n=1), Northern 
Ireland (UK) (n=1), Republic of Ireland (n=3), and the USA (n=2). The identification 
of studies conducted in only English speaking countries was probably due to 
selection of language as English. This literature review revealed that most of these 
studies were conducted within a regional context such as a study by Lindsay el al.24 
conducted in Brisbane, Australia; a study by Lindsay et al.29 in the province of 
Alberta, Canada; a study by Seymour and Kerr31 in the Trent region, England; a study 
by Tabasam and Johnson41 in North England and a study by Wong et al.42 in the 
Northeast and mid-Atlantic regions of the USA. 
This literature review found that the ‘cross sectional survey’ design with a 
postal questionnaire was the method most used. However, Kitchen28 used face-to-
face interviews for their survey and Al-Mandeel and Watson,40 who conducted an 
audit, reviewed patients’ case files / records to extract the data on the use of 
electrotherapy. In the reviewed studies, research participants were 
physiotherapists; however, physiotherapy departments through their 
representatives were also recruited as participants in some studies.24, 33, 34, 36  Most of 
the studies involved physiotherapists working in the public sector while a few 
studies24, 29 involved only private practitioners. Physiotherapists working in both 
private and public sectors were involved in some studies.28, 33, 35, 36, 39 In addition, this 
review revealed that some studies involved specialized physiotherapists for 
particular clinical conditions. For example, a study by Taylor and Humphry26 
involved physiotherapists specialized in physical disabilities; Seymour and Kerr31 
involved only community physiotherapists; Warden and McMeeken38 involved 
physiotherapists interested in sports injuries; Shields et al.37 involved only senior 
physiotherapists; Chipchase and Trinkle39 included physiotherapists interested in 
the musculoskeletal field and Wong et al.42 involved physiotherapists specialized in 
orthopaedics. Moreover, a few studies investigated the use of electrotherapy in 
treating particular medical conditions. For example, the use of EPAs in the 
management of pain was studied by Tabasam and Johnson41 and Scudds et al.43  
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In the reviewed studies, the sample sizes varied from 10 participants28 to a 
maximum of 12,893 participants.18 However, a few studies did not provide the exact 
sample size. For example, Wong et al.42 did not provide any information on their 
sample size while Lindsay et al.29 reported their sample size as ‘all private 
practitioners registered in Alberta, Canada’ and did not provide the exact number of 
the private practitioners. The response rate also varied widely in the reviewed 
studies from 27%18 to the highest response rate at 99.3%.36 
The findings of this literature review showed that some studies investigated 
only one electrotherapy modality such as therapeutic ultrasound studied by Warden 
and McMeekan,38 Chipchase and Trinkle39 and Wong et al.,42 PSWD by Al-Mandeel 
and Watson,40 interferential by Tabasam and Johnson41 and laser by Baxter et al.25 
and McMeekan and Stillman.27 Shields et al.36, 37studied two shortwave modalities i.e. 
PSWD and CSWD. The remaining studies investigated more than two electrotherapy 
modalities. Only three studies i.e. Pope et al.,23 Cooney et al.,35 and Shah et al.16 
studied several modalities including US, PSWD, CSWD, MWD, TENS, interferential, 
biofeedback, laser and H-wave (Table 2). 
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Table 2 Types of electrotherapy modalities investigated in the reviewed studies  
 Study / Reference Year Country / Location US* PSWD CSWD Laser IFT* TENS BFD* MWD H-wave 
Lindsay et al.24 1990 Australia (Brisbane)        
Baxter et al.25 1991 Northern Ireland         
Taylor and Humphry26 1991 USA        
McMeeken and Stillman27 1993 Australia (Victoria)         
Kitchen28 1995 England         
Lindsay et al.29 1995 Canada (Alberta)       

Pope et al.23 1995 England        
Kitchen and Partridge30 1996 England         
Seymour and Kerr31 1996 
England (Trent 
region) 
       
Kitchen and Partridge32 1997 England         
Robertson and Spurritt33 1998 Australia        
Partridge and Kitchen34 1999 England and Wales       

Cooney et al.35 2000 Republic of Ireland        
Shields et al.36 2001 Republic of Ireland         
Shields et al.37 2002 Republic of Ireland         
Warden and McMeeken38 2002 Australia (Victoria)         
Chipchase and Trinkle39 2003 Australia (South)         
Al-Mandeel and Watson40 2006 England   
     
Tabasam and Johnson41 2006 England (North)        
Shah et al.16 2007 England (South)        
Wong et al.42 2007 
USA (Northeast/Mid-
Atlantic regions) 
        
Chipchase et al.18 2009 Australia        
Scudds et al.43 2009 Hong Kong and UK       

 *US = ultrasound, IFT =interferential, BFD= Biofeedback 
 
The findings of our literature review regarding the trends in the availability and 
non-availability as well as use and non-use despite availability of nine 
electrotherapy modalities are presented, in the order of high to low number of 
studies that investigated these modalities, in the following sub-sections. 
Ultrasound (US) 
Ultrasound was the most commonly studied modality in the reviewed literature. 
This modality was reported in 17 out of 23 studies (73.9%) included in this review. 
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Four studies26, 38, 39, 42 investigated only ultrasound and 13 other studies investigated 
ultrasound along with other modalities (Table 2). However, not all the studies 
reported statistics on the variables ‘availability’, ‘use’, ‘non-use despite availability’ 
and ‘non-availability’ of this electrotherapy modality. For example, Taylor and 
Humphry26 and Syemour and Kerr31 did not report data on the availability and non-
availability whereas Kitchen28 did not report data on ‘use’ and ‘non-use despite 
availability’. In addition, Scudds et al.43 did not report statistics on all these four 
variables and provided data on use of only ultrasound in comparison to other EPAs 
for pain management. Moreover, Pope et al.23 reported the number of 
physiotherapists (n=212) who had access to ultrasound equipment; therefore, we 
determined by the calculation method explained in the last paragraph of the 
methods section that the availability of ultrasound was 99.5% in their study. Data on 
the availability and use of ultrasound extracted from the reviewed studies showed 
that the availability of this modality was very high between 1990 and 2009; 
however, the availability of ultrasound started to decline more recently (Figure 2).  
The use of ultrasound was high i.e. between 70% and 100% but fitting of a 
linear trend line showed a declining trend in the use of this modality, especially from 
2003 to 2009. Non-use despite availability of this modality was low but it showed an 
increasing trend. Similarly, non-availability of this modality was very low from 1990 
but it rose to 10% in 2009 (Figure 2).  
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Figure 2 Availability, use, non-use and non-availability of ultrasound (1990 to 2009) 
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Pulsed shortwave diathermy (PSWD) 
Pulsed shortwave diathermy (PSWD) was also one of the most commonly studied 
electrotherapy modalities in the reviewed literature. This modality was investigated 
in 16 out of 23 studies (69.6%)  included in this literature review. Study of only 
PSWD was conducted by Al-Mandeel and Watson40, two studies by Shields et al.36, 37 
investigated the PSWD modality along with continuous shortwave diathermy 
(CSWD) while in the remaining studies (n=13) PSWD was studied in conjunction 
with other modalities (Table 2). A few of these studies did not report data on all or 
some of the four variables i.e. ‘availability’, ‘use’, ‘non-use despite availability ’and‘ 
non-availability’ for this modality. For example, study by Lindsay29 and Syemour and 
Kerr31 did not report on the four variables above while Kitchen28 reported data only 
on the availability of this modality. Scudds et al.43 reported data on the use but for 
combined shortwave diathermy (SWD); hence, it was not possible to extract data for 
only PSWD from their study. In addition, Pope et al.23 reported only the number of 
physiotherapists (n=209) having access to PSWD equipment. We therefore, 
calculated that the availability of PSWD was 98.1% in the study by Pope et al.23 
Data on the availability and use of PSWD extracted from the reviewed 
studies (presented in Figure 3) revealed that the availability of this modality was 
highly variable with highest (>90%) availability during 1995, 1997 and 2002 while 
the lowest availability (11%) was reported in 2009. The highest (97%) use of PSWD 
was reported in 1995 by Pope et al.23; however, the use of this modality started 
declining afterwards. In 2002, the use of PSWD was 45%37 and in 2009, the use of 
this modality was less than 1% reported by Chipchase et al.18 Fitting of linear trend 
lines across the abstracted data on the availability and use of PSWD revealed 
considerable declining trends in the availability and use of this modality (Figure 3). 
The non-use despite availability of PSWD varied from 3% in 1995,23 55% in 
200237 to 96% in 2009.18 The non-availability of this modality was fluctuating. In 
1990, it was 81%,24 in 1995 it was 2%,17, 23 in 2006 the percentage increased to 6%37 
and in 2009 it was 89%.18 Linear trend lines fitted across the non-use despite 
availability and the non-availability data for this modality showed a rising trend for 
both of these parameters of PSWD (Figure 3).  
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Figure 3 Availability, use, non-use and non-availability of PSWD (1990 to 2009) 
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Continuous shortwave diathermy (CSWD) 
Continuous shortwave diathermy was another commonly studied electrotherapy 
modalities in the reviewed literature. CSWD was not studied as a single modality in 
any of the studies included in this review. However, CSWD was studied in 
conjunction with other modalities (Table 2). This modality was investigated in 14 
out of the 23 studies (60.9%). This indicated that the number of studies of CSWD 
was lower than the number of studies that investigated ultrasound and PSWD 
(Table 2). It is also important to point out that a few studies did not provide data on 
the ‘availability’, ‘use’, ‘non-use despite availability’ and ‘non-availability’ of this 
modality. For example, a study by Lindsay29 did not report extractable data on all of 
the above four variables with respect to CSWD. Kitchen28 did not report data on ‘use’ 
and ‘non-use’ of CSWD despite equipment availability. Scudds et al.43 reported data 
on the use of combined shortwave diathermy; therefore, extraction of data for only 
CSWD was not possible from their study. As mentioned earlier, Pope et al.23 reported 
only the number of physiotherapists (n=196) having access to CSWD equipment. As 
mentioned earlier, we therefore calculated the availability of CSWD as 85% in the 
study by Pope et al.23 
Data on the availability and use of CSWD extracted from the reviewed 
studies (shown in Figure 4) revealed that the availability of this modality was very 
high i.e. about 85% during 199523 and 93% in 200237 while the lowest availability 
(12%) was reported in 2009.18 The use of CSWD fluctuated considerably between 
1990 and 2009. The highest use (86%) of CSWD was reported in 1998 by Robertson 
and Spurritt,33 which declined to 56% in 200237 and reached the lowest level (5%) 
in 2009.18 Fitting of linear trend lines across the data on the availability and use of 
CSWD revealed considerable declining trends in both the availability and the use of 
this modality.  
‘Non-use despite availability’ of this modality varied from 14% in 199833 to 
44% in 200237 to 95% in 2009.18 ‘Non-availability’ of CSWD was lowest (7%) in 
200237 but it increased to 88% in 2009.18 Linear trend lines fitted across the ‘non-
use despite availability’ and the ‘non-availability’ data for CSWD showed a rising 
trend for both these parameters for this modality (Figure 4).  
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Figure 4 Availability, use, non-use and non-availability of CSWD (1990 to 2009) 
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Laser 
Therapeutic laser was also one of the most commonly studied modalities in the 
reviewed literature. This modality was investigated in 13 out of 23 studies (56.5%) 
included in this literature review. Two studies25, 27 investigated only laser while the 
remaining 11 studies investigated laser along with other electrotherapy modalities 
(Table 2). Nevertheless, the data for laser on all or some of the four variables (i.e. 
‘availability’, ‘use’, ‘non-use despite availability’ and ‘non-availability’) were not 
provided in some of these studies. For example, studies by Baxter et al.25 and 
McMeeken and Stillman27 did not report extractable data on the above four variables 
with respect to laser. A study by Kitchen28 reported data only on the availability of 
this modality but did not report data on the other three variables. Partridge and 
Kitchen34 reported data on the ‘use’ and ‘non-use’ of laser but they did not report 
data on the ‘availability’ and ‘non-availability’. As reported earlier regarding the 
study by Pope et al.,23 we determined the availability of laser  to be 84.8%. Data on 
the ‘availability’, ‘use’, ‘non-use despite availability’ and ‘non-availability’ of laser 
extracted from the reviewed studies (shown in Figure 5) indicated that the 
availability of this modality was highest (92%) in 1995.23 However, it declined in the 
subsequent years. Therefore, the availability of this modality showed an overall 
declining trend (Figure 5).  
The use of laser increased from 58% in 199024 to 100% in 1998.33 However, 
its use decreased to 59% in 200035 and reached the lowest level of 19% in 2009.18 
Therefore, the use of laser overall showed a steady increasing trend from 1990 to 
2000; however, data showed a slightly declining trend for laser use after 2000 
(Figure 5). ‘Non-use of laser despite availability’ of equipment was 42% in 199024 
but declined to 0% in 1998.33 However, it increased to 41% in 200035, almost 
doubling to 81% in 2009.18 Consequently, the data for the ‘non-use despite laser 
equipment availability’ showed an increasing trend (Figure 5). The non-availability 
of laser fluctuated in the last twenty years; however, the data extracted from the 
reviewed studies revealed overall a slowly rising trend in the ‘non-availability’ of 
this modality (Figure 5).  
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Figure 5 Availability, use, non-use and non-availability of laser (1990 to 2009) 
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Interferential  
This literature review revealed that interferential modality was also one of the 
commonly studied electrotherapy modalities. This modality was investigated in 12 
out of 23 studies (52.2%) included in this review (Table 2). A study by Tabasam and 
Johnson41 studied only this modality while the remaining ten studies studied 
interferential along with other modalities (Table 2). It is important to point out that 
Tabasam and Johnson41 studied treatment with interferential by auditing / 
reviewing patients’ case files and they did not report statistics on the ‘availability’, 
‘use’, ‘non-use’ and ‘non-availability’ of equipment with respect to this modality in 
physiotherapy departments. In addition, Taylor and Humphry26 and Seymour and 
Kerr31 reported data on the ‘use’ and ‘non-use’ of interferential but they did not 
report data on the overall ‘availability’ and ‘non-availability’ of this modality. Two 
further studies29, 34 also did not report extractable data with respect to this modality. 
Pope et al.23 reported the total number of physiotherapists (n=207) having access to 
interferential equipment and from this figure we determined the equipment 
availability of this modality to be 97% in the study by Pope et al.23 
Data on the’ availability’, ‘use’, ‘non-use’ and ‘non-availability’ of 
interferential extracted from the reviewed studies (presented in Figure 6) showed a 
slightly declining trend of the availability and use of interferential modality. 
Although the use of this modality increased from 90% in 1990 to 100% in 2000, it 
declined by about 25% in 2009 compared to 2000 (Figure 6). The lowest use of this 
modality was 66% in 1998.33 The ‘non-use’ of interferential was highest (about 
35%) in 199833 while the ‘non-use’ of this modality was reported zero by Cooney et 
al. in 200035 and Shah et al.16 However, the ‘non-use’ of interferential again 
increased to 24% in 2009.18 Similarly, the ‘non-availability’ of interferential 
equipment was 15% in 199024, and decreased to 2% in 200035 but it increased again 
and reached 28% in 2009.18 Therefore, the ‘non-availability’ of interferential 
equipment revealed an overall increasing trend (Figure 6). 
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Figure 6 Availability, use, non-use and non-availability of interferential (1990 to 2009) 
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Transcutaneous electrical nerve stimulation (TENS) 
Transcutaneous electrical nerve stimulation was one of the commonly studied 
electrotherapy modalities in the reviewed literature. This modality was studied in 
11 out of 23 studies (47.8%) included in this review (Table 2). Taylor and 
Humphry26 studied only TENS while the other ten studies investigated TENS along 
with other modalities (Table 2). Three studies26, 31, 34 reported data on the ‘use’ and 
‘non-use’ of TENS but they did not report data on the overall ‘availability’ and ‘non-
availability’ of this modality. A study by Lindsay et al.29 did not report extractable 
data with respect to this modality. As mentioned earlier, we determined the 
availability of this modality as 98.1% in the study by Pope et al.23 The statistics on 
the ‘availability’, ‘use’, ‘non-use’ and ‘non-availability’ of TENS extracted from the 
reviewed studies revealed that the availability of TENS equipment presented a 
slightly declining trend (Figure 7). 
The use of this modality showed an increasing trend from 1990 to 2000; 
however, the use of this modality decreased by about 30% in 2009 compared to 
2000 (Figure 7). In addition, there was a declining trend in the ‘non-use despite 
availability’ of TENS; thus, the ‘non-availability’ of equipment of this modality 
suggested overall a slightly increasing trend.  
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Figure 7 Availability, use, non-use and non-availability of TENS (1990 to 2009) 
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Biofeedback 
This literature review showed that the biofeedback modality was one of the less 
commonly studied electrotherapy modalities in the reviewed studies (Table 2). 
Biofeedback was investigated in seven out of 23 studies (30.4%) included in this 
review (Table 2). In these seven studies, biofeedback was investigated in association 
with other modalities (Table 2.2). Lindsay et al.29 did not report extractable data 
with respect to this modality. Two studies33, 35 did not report data on the 
‘availability’ and ‘non-availability’ of biofeedback equipment; however, they 
presented data on the ‘use’ and ‘non-use’ of this modality. In addition, Pope et al.23 
also did not report data with respect to the overall availability of this modality. 
Therefore, the availability of this modality was determined by us as 83% in the 
study by Pope et al.23 Data on the ‘availability’, ‘use’, ‘non-use’ and ‘non-availability’ 
of interferential extracted from the reviewed studies are presented in Table 3. 
 
Table 3 Availability, use, non-use and non-availability of Biofeedback (1990-2009) 
Year (Study) 
Available 
(%) 
Used 
(%) 
Not used despite 
availability (%) 
Not available 
(%) 
1990 (Lindsay et al)24 24 18 83 77 
1995 (Pope et al)23 83 94 6 17 
1998 (Robertson and Spurrit)33 32 NA NA 68 
2000 (Cooney et al)35 3 NA NA 97 
2007 (Shah et al)16 84.8 65.2 17.4 15.2 
2009 (Chipchase et al)18 52 43 58 48 
 
The extracted data (Table 3) showed that the availability of biofeedback 
fluctuated between 1990 and 2009. In 1995, Pope et al.23 reported availability of 
biofeedback as 83% which declined to the lowest level of 3% in 2000 as reported by 
Cooney et al.35 However, the availability of this modality increased in the later years 
to 85% reported by Shah et al.16 and it declined once again to 52% in 2009 as 
reported by Chipchase et al.18 The use of this modality was lowest (18%) in 199024 
and highest (94%) in 1995.23 However, the use of this modality decreased and 
reached about 43% in 2009.18 The ‘non-use’ of biofeedback was highest (83%) in 
199024 and lowest (2.2%) in 2007.16 However, it increased to 58% in 2009.18 The 
‘non-availability’ of biofeedback equipment was highest (97%) in 200035 but it 
declined to the lowest of 15.2% in 2007.16 Overall, the ‘availability’ and ‘non-
availability’ of this modality fluctuated in the reviewed studies. 
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Microwave diathermy (MWD) 
Microwave diathermy was also a less commonly studied electrotherapy modality in 
the reviewed literature. This modality was investigated in only six (26.1%) out of 23 
studies included in this review. MWD was not studied as a single modality in any of 
the 23 studies included in this review but was studied along with other 
electrotherapy modalities (Table 2). As reported earlier, we calculated the 
availability of MWD as 83.6% in the study by Pope et al.23 In addition, Cooney et al.35 
reported use of MWD as the ‘least used’ but did not report any statistics on the ‘non-
use despite availability’ of MWD equipment. A later study by Shah et al.16 conducted 
in southeast and southwest of England showed that MWD was not available and not 
used in the NHS physiotherapy departments included in their survey. Table 4 
presents the statistics on the ‘availability’, ‘use’, ‘non-use’ and ‘non-availability’ of 
MWD extracted from the reviewed studies.  
The findings showed that the availability of this modality was highest (84%) 
in 199523 and decreased considerably to 6% in 200035; falling to the lowest level 
(2%) in 2009.18 The ‘use’ of MWD was between 64% and 79% from 1990 to 1998; 
however, it declined to very low use from 2000 to none in 2007. Similarly, the ‘non-
availability’ of MWD was higher ranging from 67% in 199024 to 93% in 199833 and 
100% in 2007.16 However the lowest ‘non-use’ of MWD (21%) despite equipment 
availability was reported by Pope et al. in 1995.23 The greater difference in the ‘non-
availability’ of MWD might be due to the differences in the location of studies. For 
example, the Pope et al. study23 was conducted in England while other studies on 
MWD were conducted in Australia18, 24, 33and in the Republic of Ireland35 as shown in 
Table 2. The data on MWD presented in Table 4 revealed that the overall availability 
and use of this modality showed a declining trend while the ‘non-use’ and ‘non-
availability’ presented an increasing trend in the reviewed studies.  
 
Table 4 Availability, use, non-use and non-availability of MWD (1990-2009) 
Year (Study) Available 
(%) 
Used (%) Not used despite 
availability (%) 
Not available 
(%) 
1990 (Lindsay et al)24 33 79 21 67 
1995 (Pope et al)23 84 64 36 16 
1998 (Robertson and Spurritt)33 7 75 25 93 
2000 (Cooney et al)35 6 Least  used  Not reported 94 
2007 (Shah et al)16 0 0 0 100 
2009 (Chipchase et al)18 2 0.6 99 98 
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H-wave 
H-wave was the least studied modality in the reviewed literature. It was investigated 
in only 13% i.e. three of the 23 studies included in this review (Table 2). Data 
extracted from these studies on the ‘availability’, ‘use’, ‘non-use despite availability’ 
and ‘non-availability’ of equipment is presented in Table 5.  
The findings showed that the availability and use of H-wave was highest in 
1995.23 However its lowest availability was 2% in 200035 and the lowest use was 
34% in 2007.16 There were no data on the ‘use’ and ‘non-use despite availability’ of 
this modality reported in the study by Cooney et al.35 The highest non-availability of 
this modality was 98% in 200035 but it declined to 93.5% in  2007.16 Overall, the 
reviewed literature showed that the availability of H-wave was at the verge of 
disappearing and its non-availability in physiotherapy departments was becoming 
widespread from 2000 onwards. 
 
Table 5 Availability, use, non-use and non-availability of H-wave (1995-2007) 
Year (Study) 
Available 
(%) 
Used  
(%) 
Not used despite 
availability (%) 
Not available (%) 
1995 (Pope et al)23 82 97 3 18 
2000 (Cooney et al)35 2 Not reported Not reported 98 
2007 (Shah et al)16 6.5 33.8 0 93.5 
 
 
DISCUSSION  
This literature review comprised a review of 23 studies. Our detailed comments on 
each of the studies included in this literature review are given in Table 1. Overall, we 
found that most of the studies were conducted on a regional level with a small 
sample size; hence, the findings of these studies have limited generalizability. In 
addition, reporting of the data in these studies varied; therefore, it was difficult to 
extract the required data on the same parameters from all of the studies.  
Our findings of the present literature review show overall patterns in the availability 
and usage of nine electrotherapy modalities as follows. Therapeutic ultrasound was 
the most available (90% to 100%) and used (70% to 100%) since 1990. The reasons 
for widespread use of ultrasound could be the ease of application and portability.24 
However, ultrasound non-use despite availability has increased recently, especially 
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in Australia (22%)18 and there are calls for trials to study clinical effectiveness of 
ultrasound.39, 42, 44  
Our findings show that PSWD availability and usage is high in the UK and the 
Republic of Ireland but low in Australia. The non-use of PSWD despite equipment 
availability is low in England compared to the Republic of Ireland and Australia. 
Overall, the non-use of PSWD despite availability of equipment has greatly increased 
in the recent years, especially in Australia (96%)18 where it is mostly non-available 
(89%)18. CSWD shows a declining trend in availability and use while its non-
availability and non-use despite equipment ownership shows rising trends, which 
might be due to safety concerns.44-46  
For laser, availability is slightly decreasing, and use shows a substantial 
declining trend while its non-availability and non-use despite availability shows 
increasing trends. Interferential shows a steady but declining trend in availability 
and use; however, its non-availability and non-use despite equipment ownership 
show slightly rising trends, especially in Australia. Also, there is demand for more 
research on clinical effectiveness of interferential.35 Trends for TENS show a low 
decline in availability and non-use despite ownership; however, its use and non-
availability show moderately increasing trends. The non-use of this modality is 
higher in Australia compared to the UK. In addition, further research on the clinical 
effectiveness of TENS has been suggested.43, 45, 46 Biofeedback is highly available and 
used in England compared to in Australia and the Republic of Ireland where this 
modality was mostly non-available during the review period. The non-use of this 
modality is the highest in Australia.  
Our review has revealed that MWD availability and use show a very steep 
decline from 1990 to 2009 while its non-availability and non-use despite equipment 
ownership was the highest of all electrotherapy modalities included in this review. 
In addition, we found greater differences in the degree of ‘non-availability’ of MWD 
in the reviewed studies, which might be due to the differences in the location of 
studies. For example, the Pope et al. study23 was conducted in England while other 
studies on MWD were conducted in Australia18, 24, 33 and in the Republic of Ireland35 
as shown in Table 2. It is also imperative to note that only one study i.e. Shah et al.16 
reported 100% non-availability hence non-use of this modality in England. The main 
reasons for widespread non-use of MWD may be safety concerns for patients34 and 
physiotherapists44-46 and supersession of this modality.35 
Trends in the availability and the use of H-wave showed a great decline 
while its non-availability was found steeply increasing during the last two decades. 
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The main reasons for widespread non-use of this modality might be due to its 
supersession.35  
In summary, our findings suggest that electrotherapy modalities studied in 
this review can be divided in four categories. The first category includes the most 
commonly available and used modalities that are ultrasound, interferential, TENS 
and biofeedback. The second category comprises frequently available and used 
modalities that include PSWD and laser. The third category consists of CSWD, which 
is a rarely used modality. The fourth (last) category contains MWD and H-wave, 
which are very rarely used electrotherapy modalities and they are at the verge of 
disappearance from physiotherapy practice. 
This literature review has also revealed that there have been differences in 
the availability and usage of electrophysical agents in physiotherapy practices in the 
last twenty years. These differences varied between electrotherapy modalities, 
between countries, between public and private physiotherapy practices, and 
between the years of the studies. Differences in the use and availability of EPAs 
might be determined by differences in these countries in terms of electrotherapy 
education and training,43 and the nature of clinical practices.35, 43 In addition, use of 
electrotherapy is determined by several factors such as the equipment availability,30, 
44 reputation of being safe, such as for ultrasound and TENS,24, 47, 48 physiotherapists’ 
experience and belief about effects of the modality,49 the clinical effectiveness50 the 
type of medical condition30, 49 and the nature of physiotherapy practices.16, 24, 27 
Overall, the emerging trend for electrotherapy revealed in this review is that the use 
of these EPAs is declining and their non-availability is rising, which may be due to 
several reasons (Table 6). The most common reasons for non-use of EPAs include 
lack of evidence for clinical effectiveness, non-availability of equipment, safety 
concerns, and lack of knowledge / familiarity with and training in using these 
electrotherapy modalities. 
In addition, the non-use and non-availability of these modalities might have 
implications for their purchasers, users (clinicians and patients) as well as 
manufacturers and suppliers. Non-use despite equipment availability for some of 
these modalities is a waste of resources for the purchasers of this costly 
equipment.16 
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Table 6 Reasons for non-use of electrophysical agents in physiotherapy practices 
Reasons for non-use References  
Non-availability of equipment 17, 30, 44  
Safety concerns / fear of safety  11, 24, 33, 47 
Lack of evidence for clinical effectiveness 11, 27, 28, 33, 35-37, 43, 50-52 
Physiotherapist’s choice  23,15 
Lack of knowledge / training and unfamiliarity with the modality 23, 35, 52, 53 
Lack of research and information on EPAs  25, 27  
Nature of the clinical condition being treated  30 
Supersession of modality e.g. MWD and H-wave  35 
Level of ease of / difficulty in application   24 
Area / nature of practice i.e. private vs. public sector use, and busy 
vs. less busy practice  
50, 54 
 
Cost of the equipment, especially for private practices 23, 35, 50 
 
The non-use might lead to non-purchase of the latest models, which might 
affect the medical device industry. Non-availability and non-use despite availability 
might also have an impact on patients who might require use of particular EPAs. For 
example, use of electrotherapy might be useful for some patients but they might not 
be provided or treated with the required EPA for a variety of reasons including lack 
of scientific evidence of effectiveness. Such cases have been suggested as  denying a 
potential benefit for the patient.2  
Other implications of non-use and non-availability include impact on 
physiotherapy teaching, training and practice, such as removal of MWD in some text 
books on evidence based electrotherapy practice20 and subsequent effect on 
undergraduate  curriculum and practical training for EPA.21, 33, 51 This shift away 
from electrotherapy would probably change the nature of physiotherapy practice 
with less electrotherapy and more non-electrotherapeutic treatments in the future. 
However, accepting or abandoning any EPA without systematic research and 
scientific evidence cannot be supported. Most commonly, it has been noticed that a 
lack of clinical effectiveness has been suggested to be the main reason for not using 
some of these electrotherapy modalities. However, this attitude towards EPAs has 
been challenged by some practitioners from within the physiotherapist community. 
For example, Watson2 is of the view that there is difference between lack of evidence 
and evidence of lack and he has suggested that physiotherapists might adopt 
alternative treatment approaches and use their own experiences and expert 
opinions when there is no published evidence regarding EPAs.  
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Any future research therefore should systematically investigate the issue of 
lack of clinical effectiveness of electrophysical agents used in physiotherapy practice 
and suggest recommendations for teaching and training for effective and safe use of 
EPAs to future physiotherapists.     
CONCLUSION 
Of the nine electrophysical agents studied in this review, ultrasound is the most 
commonly available and used modality across the countries studied during the last 
twenty years. There is also a high availability and use of interferential, TENS and 
biofeedback in different countries. PSWD is commonly used in England and the 
Republic of Ireland compared to Australia; however, its non-use despite equipment 
availability is higher in Australia and the Republic of Ireland compared to England. 
The availability and non-availability of laser is moderate but its use is declining 
while non-use despite equipment availability is rising. CSWD is a less commonly 
available and used modality across the countries and its non-availability and use 
despite device availability is increasing. MWD and H-wave are the least available 
modalities and their use is steeply declining while their non-availability is the 
highest of all EPAs included in this review. 
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